Screening of Apob Gene Mutations in Subjects with Clinical Diagnosis of Familial Hypercholesterolemia

Monogenic hypercholesterolemia is a group of lipid disorders, most of which have autosomal dominant transmission. Familial defective apoB (FDB) resulting from mutations in the APOB gene is a well-recognized cause of autosomal dominant monogenic hypercholesterolemia (ADMH). However, the frequency of FDB among patients with ADMH is not well established. The aim of our research was to screen for mutations responsible for FDB in subjects with a clinical diagnosis of familial hypercholesterolemia. We studied 408 patients from the Spanish Register of Familial Hypercholesterolemia, proportionally distributed among all Spanish regions. Abnormal SSCP patterns of the APOB gene were checked by DNA sequencing and restriction analysis. Three out of the 408 patients were carriers of the R3500Q mutation, and 2 subjects were carriers of the silent T3552T mutation; in both of these patients functional mutations in the LDL receptor gene were found. We conclude that FDB is not a common cause of ADMH in Spain; the R3500Q mutation is the only mutation in APOB causing FDB, and the LDL receptor binding domain of APOB is highly conserved in the studied sample

Apolipoprotein B · Biology · Cholesterol · Familial hypercholesterolemia · Gene · Gene mutation · LDL receptor · Lipoprotein · Mutation · Single-strand conformation polymorphism · Cholesterol and Lipid Metabolism · Diabetes, Cardiovascular Risks, and Lipoproteins · Endocrinology · Genetics · Internal Medicine · Lipoproteins and Cardiovascular Health · Medicine